40 Results

People

  1. Arcila
    Arcila
  2. Ladanyi
    Ladanyi
  3. Solit
    Solit
  4. Kris
    Kris
  5. Berger
    Berger
  6. Zehir
    Zehir
  7. Drilon
    Drilon
  8. Li
    Li
  9. Riely
    Riely
  10. Rudin
    Rudin

Groups

  1. Department of Medicine (35)
  2. GSK Faculty (26)
  3. Human Oncology and Pathogenesis Program (25)
  4. Solid Tumor Oncology Division (24)
  5. Tow Center for Developmental Oncology (TCDO) (20)
  6. Hematologic Malignancies, Division of (17)
  7. Center for Hematologic Malignancies (15)
  8. Sloan Kettering Institute Postdocs (15)
  9. Epidemiology and Biostatistics (14)
  10. Thoracic Oncology (13)
  1. "male"
  2. "Maria Arcila"
Formats
  1. Journal Article (39)
  2. Editorial (1)
Groups
  1. Department of Medicine (35)
  2. GSK Faculty (26)
  3. Human Oncology and Pathogenesis Program (25)
  4. Solid Tumor Oncology Division (24)
  5. Tow Center for Developmental Oncology (TCDO) (20)
  6. Hematologic Malignancies, Division of (17)

More Groups

People
  1. Maria Arcila (40)
  2. Marc Ladanyi (14)
  3. David Solit (9)
  4. Ahmet Zehir (8)
  5. Mark Kris (8)
  6. Michael Berger (8)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (5)
  5. 2020 (7)
  6. 2019 (6)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. Modern Pathology (3)
  3. Cancer (2)
  4. Cancer Discovery (2)
  5. European Urology Focus (2)
  6. Genes Chromosomes and Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. Elsevier Inc. (4)
  3. Elsevier Science, Inc. (3)
  4. Nature Publishing Group (3)
  5. Nature Research (3)
  6. American Medical Association (2)

More Publishers

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Tumor genomic profile is associated with arterial thromboembolism risk in patients with solid cancer
    Journal Article

    Feldman, S.; Gupta, D.; Navi, B. B.; Ho, K. W. G.; Willeit, P.; Devlin, S.; Bolton, K. L.; Arcila, M. E.; Mantha, S.
    JACC: CardioOncology (2023)

    Fulltext@MSK | Save
  • AACR project GENIE: 100,000 cases and beyond
    Journal Article

    Pugh, T. J.; Bell, J. L.; Bruce, J. P.; Doherty, G. J.; Galvin, M.; Green, M. F.; Hunter-Zinck, H.; Kumari, P.; Lenoue-Newton, M. L.; Li, M. M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • TP53 combined phenotype score is associated with the clinical outcome of TP53-mutated myelodysplastic syndromes
    Journal Article

    Yabe, M.; Omarbekova, A. Z.; Hsu, M.; May, H.; Arcila, M. E.; Liu, Y.; Dogan, A.; Brunner, A. M.; Nardi, V.; Hasserjian, R. P.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience
    Journal Article

    Aypar, U.; Yao, J.; Londono, D. M.; Khoobyar, R.; Scalise, A.; Arcila, M. E.; Roshal, M.; Xiao, W.; Zhang, Y.
    Genes Chromosomes and Cancer (2021)

    Fulltext@MSK | Save
  • RAS/MAPK pathway driver alterations are significantly associated with oncogenic KIT mutations in germ-cell tumors
    Journal Article

    Mata, D. A.; Yang, S. R.; Ferguson, D. C.; Liu, Y.; Sharma, R.; Benhamida, J. K.; Al-Ahmadie, H. A.; Chakravarty, D.; Solit, D. B.; Tickoo, S. K.; more...
    Urology (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
    Journal Article

    Lewis, N. E.; Petrova-Drus, K.; Huet, S.; Epstein-Peterson, Z. D.; Gao, Q.; Sigler, A. E.; Baik, J.; Ozkaya, N.; Moskowitz, A. J.; Kumar, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save